🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

850 results for “Elan” Clear

  1. TD-1473 oral capsule

    Theravance Biopharma Ireland Umited

    Intestinal Disorders

    phase 1 small molecule completed

    1 trial

  2. TD-1607

    Theravance Biopharma Ireland Umited

    Infections

    phase 1 small molecule completed

    1 trial

  3. TD-1607

    Theravance Biopharma Ireland Umited

    Serious Infections Due to Known or Suspected Gram-positive Pathogens

    phase 1 small molecule completed

    1 trial

  4. TD-3504

    Theravance Biopharma Ireland Umited

    Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects

    phase 1 small molecule completed

    1 trial

  5. TD-4208

    Theravance Biopharma Ireland Umited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  6. TD-4208

    Theravance Biopharma Ireland Umited

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  7. TD-4208 175 mcg

    Theravance Biopharma Ireland Umited

    Cardiac Repolarization in Healthy Subjects

    phase 1 small molecule completed

    1 trial

  8. TD-5202

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  9. TD-6450

    Theravance Biopharma Ireland Umited

    Hepatitis C

    phase 1 small molecule completed

    2 trials

  10. TD-8954

    Theravance Biopharma Ireland Umited

    Gastrointestinal Motility Disorder

    phase 1 small molecule terminated

    1 trial

  11. TD-9855

    Theravance Biopharma Ireland Umited

    Drug Drug Interaction (DDI)

    phase 1 small molecule completed

    1 trial

  12. TD-9855

    Theravance Biopharma Ireland Umited

    ADHD

    phase 1 small molecule completed

    1 trial

  13. Telavancin

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  14. Triamcinolone Acetonide Extended-Release Injectable Suspension

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 1 small molecule completed

    1 trial

  15. VSA001 injection

    Arrowhead Pharmaceuticals Ireland Limited

    Healthy Adult Volunteers

    phase 1 small molecule completed

    1 trial

  16. Velusetrag

    Theravance Biopharma Ireland Umited

    Alzheimer's Disease

    phase 1 small molecule completed

    1 trial

  17. Venezuelan Equine Encephalitis DNA Vaccine

    United Therapeutics Europe Ltd

    Vaccine Reaction

    phase 1 small molecule active

    1 trial

  18. Vyxeos

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  19. Vyxeos 44 MG / 100 MG Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Relapsed Pediatric AML

    phase 1 small molecule active

    1 trial

  20. X4P-001

    X4 Pharmaceuticals, Inc

    Melanoma

    phase 1 small molecule completed

    1 trial

  21. ZW25 (Zanidatamab)

    Jazz Pharmaceuticals Ireland Limited

    HER2-expressing Cancers

    phase 1 small molecule completed

    1 trial

  22. [14C]-GSK961081 solution for IV infusion

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    1 trial

  23. [203Pb]VMT01

    Perspective Therapeutics

    Melanoma (Skin)

    phase 1 small molecule completed

    1 trial

  24. autologous cell-based delivery

    Regeneron Ireland Designated Activity Company (DAC)

    Hypoplastic Left Heart Syndrome

    phase 1 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources